(Q37081683)

18 August 2017

1 reference

title

Changing landscape of invasive aspergillosis in allogeneic stem cell transplant recipients (English)

1 reference

stem cell transplantation

18 August 2017

0 references

1 reference

based on heuristic

inferred from title

invasive aspergillosis

1 reference

E Jantunen

1

1 reference

18 August 2017

A Nihtinen

series ordinal

2

1 reference

18 August 2017

V-J Anttila

series ordinal

3

1 reference

18 August 2017

publication date

11 February 2008

1 reference

Transplant Infectious Disease

18 August 2017

published in

1 reference

18 August 2017

volume

10

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

156-161

1 reference

Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Incidence of invasive aspergillosis following hematopoietic stem cell and solid organ transplantation: interim results of a prospective multicenter surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Central nervous system aspergillosis in allogeneic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Comparison of real-time PCR, conventional PCR, and galactomannan antigen detection by enzyme-linked immunosorbent assay using bronchoalveolar lavage fluid samples from hematology patients for diagnosis of invasive pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Usefulness of sequential Aspergillus galactomannan antigen detection combined with early radiologic evaluation for diagnosis of invasive pulmonary aspergillosis in patients undergoing allogeneic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Occurrence and kinetics of false-positive Aspergillus galactomannan test results following treatment with beta-lactam antibiotics in patients with hematological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Improved outcome in central nervous system aspergillosis, using voriconazole treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

High-dose caspofungin combination antifungal therapy in patients with hematologic malignancies and hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Primary antifungal prophylaxis in leukaemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2008.00301.X

10.1111/J.1399-3062.2008.00301.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference